Getinge has received the European Union (EU) Medical Device Regulation (MDR) certificate for its Advanta V12 covered stent system.

This certification affirms the system’s compliance with EU standards for medical devices.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It also extends the stent’s indications for use, specifically for patients with aortoiliac occlusive disease (AIOD).

The Advanta V12 covered stent system is designed for the treatment of patients diagnosed with renal artery stenosis and/or aortoiliac occlusive disease, including lesions at the aortic bifurcation, when endovascular therapy is needed.

It has precision, versatility and predictability and has been serving the medical community for over two decades. It is said to be the only durable solution in its category, supported by extensive clinical and real-world evidence.

Getinge Vascular Systems vice-president Chad Carlton said: “Receiving the new EU MDR certification is a proud moment for Getinge. It is a clear reflection of our strategic vision, accompanied by the hard work and persistence of our team.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“This investment in regulatory excellence not only supports our growth ambitions and future endeavours but also reinforces our commitment to making a positive impact on the lives of the patients we serve.”

The fully encapsulated Advanta V12 stent has been designed to restore and improve the patency of the iliac and renal arteries.

Last month, Getinge secured the US Food and Drug Administration’s 510(k) clearance for its Vasoview Hemopro 3 endoscopic vessel harvesting solution for cardiovascular surgery.

The solution is designed to improve procedural efficiency and patient outcomes, with features such as enhanced smoke evacuation, regulated energy control, an ergonomic game controller-style handle, and an integrated cable.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact